Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Hematopoietic and Lymphatic System Neoplasm 1

Interventions

Interviews as Topic 12Specimen Handling 7Practice Guidelines as Topic 7Educational Status 7Standard of Care 6Methods 5Early Intervention, Educational 5Patient Navigation 3Health Promotion 3Acupressure 3Telemedicine 2Restraint, Physical 2Resistance Training 2Behavior Therapy 2Aromatherapy 2theanine 1lavender oil 1jojoba wax 1Triptorelin Pamoate 1Surveys and Questionnaires 1Spiritual Therapies 1Psychotherapy 1Psilocybin 1Outcome Assessment, Health Care 1Organizational Objectives 1Observational Studies as Topic 1Mindfulness-Based Stress Reduction 1Mindfulness 1Meditation 1Massage 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hematopoietic and Lymphatic System Neoplasm × Triptorelin Pamoate × Other solid neoplasm × Clear all
NCT06513962 2026-05-05

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

Children's Oncology Group

Phase 3 Recruiting
60 enrolled
Other solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡